Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

Cited In for PubMed (Select 10684910)

1.

Biology, detection, and clinical implications of circulating tumor cells.

Joosse SA, Gorges TM, Pantel K.

EMBO Mol Med. 2014 Nov 14;7(1):1-11. doi: 10.15252/emmm.201303698. Review.

2.

Metastasis-Initiating Cells in Renal Cancer.

Khan MI, Czarnecka AM, Duchnowska R, Kukwa W, Szczylik C.

Curr Signal Transduct Ther. 2014 Dec;8(3):240-246.

3.

Comparison of molecular and immunocytochemical methods for detection of disseminated tumor cells in bone marrow from early breast cancer patients.

Gilje B, Nordgård O, Tjensvoll K, Borgen E, Synnestvedt M, Smaaland R, Naume B.

BMC Cancer. 2014 Jul 15;14:514. doi: 10.1186/1471-2407-14-514.

4.

Single cell mutational analysis of PIK3CA in circulating tumor cells and metastases in breast cancer reveals heterogeneity, discordance, and mutation persistence in cultured disseminated tumor cells from bone marrow.

Deng G, Krishnakumar S, Powell AA, Zhang H, Mindrinos MN, Telli ML, Davis RW, Jeffrey SS.

BMC Cancer. 2014 Jun 19;14:456. doi: 10.1186/1471-2407-14-456.

5.

A germline mutation in the BRCA1 3'UTR predicts Stage IV breast cancer.

Dorairaj JJ, Salzman DW, Wall D, Rounds T, Preskill C, Sullivan CA, Lindner R, Curran C, Lezon-Geyda K, McVeigh T, Harris L, Newell J, Kerin MJ, Wood M, Miller N, Weidhaas JB.

BMC Cancer. 2014 Jun 10;14:421. doi: 10.1186/1471-2407-14-421.

6.

Monitoring in metastatic breast cancer: is imaging outdated in the era of circulating tumor cells?

Alunni-Fabbroni M, Müller V, Fehm T, Janni W, Rack B.

Breast Care (Basel). 2014 Feb;9(1):16-21. doi: 10.1159/000360438. Review.

7.

Detection of circulating tumour cells on mRNA levels with established breast cancer cell lines.

Zebisch M, Kölbl AC, Andergassen U, Hutter S, Neugebauer J, Engelstädter V, Günthner-Biller M, Jeschke U, Friese K, Rack B.

Biomed Rep. 2013 Mar;1(2):231-234. Epub 2012 Dec 5.

8.

Tumor heterogeneity in the clinic: is it a real problem?

Janku F.

Ther Adv Med Oncol. 2014 Mar;6(2):43-51. doi: 10.1177/1758834013517414. Review.

9.

Chromosomal copy number aberrations in colorectal metastases resemble their primary counterparts and differences are typically non-recurrent.

Mekenkamp LJ, Haan JC, Israeli D, van Essen HF, Dijkstra JR, van Cleef P, Punt CJ, Meijer GA, Nagtegaal ID, Ylstra B.

PLoS One. 2014 Feb 5;9(2):e86833. doi: 10.1371/journal.pone.0086833. eCollection 2014.

10.

Reliable single cell array CGH for clinical samples.

Czyż ZT, Hoffmann M, Schlimok G, Polzer B, Klein CA.

PLoS One. 2014 Jan 21;9(1):e85907. doi: 10.1371/journal.pone.0085907. eCollection 2014.

11.

Ten-year follow-up of a prospective trial for the targeted therapy of gastric cancer with the human monoclonal antibody PAT-SC1.

Hensel F, Timmermann W, von Rahden BH, Rosenwald A, Brändlein S, Illert B.

Oncol Rep. 2014 Mar;31(3):1059-66. doi: 10.3892/or.2014.2987. Epub 2014 Jan 20.

12.

The role and clinical relevance of disseminated tumor cells in breast cancer.

Banys M, Krawczyk N, Fehm T.

Cancers (Basel). 2014 Jan 15;6(1):143-52. doi: 10.3390/cancers6010143.

13.

Significance of micrometastases: circulating tumor cells and disseminated tumor cells in early breast cancer.

Oakman C, Pestrin M, Bessi S, Galardi F, Di Leo A.

Cancers (Basel). 2010 Jun 8;2(2):1221-35. doi: 10.3390/cancers2021221.

14.

Microenvironmental regulation of tumor progression and metastasis.

Quail DF, Joyce JA.

Nat Med. 2013 Nov;19(11):1423-37. doi: 10.1038/nm.3394. Review.

15.

Skeletal manifestations of treatment of breast cancer.

Choksi P, Williams M, Clark PM, Van Poznak C.

Curr Osteoporos Rep. 2013 Dec;11(4):319-28. doi: 10.1007/s11914-013-0179-7. Review.

16.

The presence and prognostic impact of apoptotic and nonapoptotic disseminated tumor cells in the bone marrow of primary breast cancer patients after neoadjuvant chemotherapy.

Hartkopf AD, Taran FA, Wallwiener M, Hagenbeck C, Melcher C, Krawczyk N, Hahn M, Wallwiener D, Fehm T.

Breast Cancer Res. 2013;15(5):R94.

17.

Circulating tumour cells in breast cancer.

Krawczyk N, Banys M, Hartkopf A, Hagenbeck C, Melcher C, Fehm T.

Ecancermedicalscience. 2013 Sep 19;7:352. doi: 10.3332/ecancer.2013.352. Review.

18.

Circulating tumor cells and DNA as liquid biopsies.

Heitzer E, Auer M, Ulz P, Geigl JB, Speicher MR.

Genome Med. 2013 Aug 23;5(8):73. doi: 10.1186/gm477. eCollection 2013. Review.

19.

Dual roles of the transcription factor grainyhead-like 2 (GRHL2) in breast cancer.

Werner S, Frey S, Riethdorf S, Schulze C, Alawi M, Kling L, Vafaizadeh V, Sauter G, Terracciano L, Schumacher U, Pantel K, Assmann V.

J Biol Chem. 2013 Aug 9;288(32):22993-3008. doi: 10.1074/jbc.M113.456293. Epub 2013 Jun 29.

20.

Detection of cancer before distant metastasis.

Coumans FA, Siesling S, Terstappen LW.

BMC Cancer. 2013 Jun 13;13:283. doi: 10.1186/1471-2407-13-283.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk